HopeStage
Back to all studies
RecruitingNCT05178069

Probiotic or placebo for alcohol use disorder and alcohol-related liver disease

About this titleRead the official source — NCT05178069
Placebo comparisonAges 21–65United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 65 years.

Listed locations
LouisvilleSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: June 1, 2022
Recruitment status
Recruiting
Enrollment listed in the registry
60
Sponsor
University of Louisville
Sponsor type
University
Study type
Drug
Intervention type
Dietary supplement, Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 21 Years to 65 Years
Official registry ID
NCT05178069
Official title
Show the full official title

Lactobacillus Rhamnosus GG: A Novel Probiotic Therapy for Treating Alcohol Use Disorder

Recruitment & locations

Currently recruiting

Louisville

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Louisville, a university.

Does this study involve medication?

Yes. The study involves medication, including : Placebo for Probiotic.

Who can participate?

Listed age limits: 21 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies